Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,171
datasets available to search
ShareScore release 0.9.0
Dataset results
6,171 results for “mutant”
Alpelisib, Fulvestrant and Dapagliflozin for the Treatment of HR+, HER2 -, PIK3CA Mutant Metastatic Breast Cancer
ClinicalTrials.gov study NCT05025735. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vorasidenib Maintenance for IDH Mutant Astrocytoma
ClinicalTrials.gov study NCT06809322. IPD Sharing: Not stated. Countries: 10. Publications: 0.
Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid Cancer
ClinicalTrials.gov study NCT04061980. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Repeatability of Magnetic Resonance Imaging in Patients With IDH1 Mutant Glioma on Ivosidenib
ClinicalTrials.gov study NCT06648473. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of T-DXd in HER2-mutant Advanced Lung Cancer Patients With Asymptomatic Brain Metastases
ClinicalTrials.gov study NCT06250777. IPD Sharing: NO. Countries: 1. Publications: 0.
Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma
ClinicalTrials.gov study NCT06008106. IPD Sharing: NO. Countries: 1. Publications: 0.
Targeted Treatment With Intercalated Radiotherapy in EGFR-mutant IIIA/IIIB NSCLC
ClinicalTrials.gov study NCT03074864. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma
ClinicalTrials.gov study NCT03543969. IPD Sharing: Not stated. Countries: 1. Publications: 0.
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in
ClinicalTrials.gov study NCT05216432. IPD Sharing: NO. Countries: 5. Publications: 0.
Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer
ClinicalTrials.gov study NCT05828082. IPD Sharing: YES. Countries: 1. Publications: 0.
TKI Followed by Thoracic Radiotherapy for Stage IV EGFR Mutant NSCLC
ClinicalTrials.gov study NCT03916913. IPD Sharing: NO. Countries: 1. Publications: 0.
Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose to the Resting State Networks
ClinicalTrials.gov study NCT04975139. IPD Sharing: NO. Countries: 1. Publications: 0.
Pemetrexed Combined With Synchronous Gefitinib as Adjuvent Therapy in Patient With EGFR Mutant Lung Adenocarcinoma
ClinicalTrials.gov study NCT02518802. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Platinum-based Chemotherapy Plus Immune Checkpoint Inhibitors for EGFR/ALK/ROS1 Mutant Lung Cancer
ClinicalTrials.gov study NCT05284539. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Osimertinib In EGFR Mutant Lung Cancer
ClinicalTrials.gov study NCT03586453. IPD Sharing: NO. Countries: 1. Publications: 0.
Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04780568. IPD Sharing: NO. Countries: 1. Publications: 0.
Simvastatin + Cetuximab/Irinotecan in K-ras Mutant Colorectal Cancer (CRC)
ClinicalTrials.gov study NCT01281761. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma
ClinicalTrials.gov study NCT03180502. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Almonertinib Followed by Chemo-immunotherapy in II-IIIB EGFR-mutant NSCLC
ClinicalTrials.gov study NCT06300424. IPD Sharing: NO. Countries: 1. Publications: 0.
Alpelisib and Capecitabine in Patients With PIK3CA Mutant mCRC Patients
ClinicalTrials.gov study NCT04753203. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.